Skip to content
OpenCapital
Get started

PAVmed Inc. PAVM Q2 2025 earnings

Reported August 14, 2025 · Before market open

Revenue$6.0KMiss by $4.0KDiluted EPS-$0.05Beat by $0.20
Revenue estimate$10.0K
EPS estimate-$0.25

Next report

Aug 13, 2026 (in a month)
Revenue estimate$48.0K
EPS estimate-$0.63

Versus estimates

Revenue

Q1 2026$22.0KMiss by $52.0KQ4 2025$52.0KBeat by $27.0KQ3 2025$5.0KMiss by $7.5K
Q2 2025$6.0KMiss by $4.0K
Q1 2025$8.0KMiss by $2.0KQ4 2024$10.0KMiss by $11.0K

Diluted EPS

Q1 2026-$1.17Miss by $0.48Q4 2025-$2.05Beat by $2.45Q3 2025-$8.41Miss by $2.40
Q2 2025-$0.05Beat by $0.20
Q1 2025-$0.07Beat by $0.22Q4 2024-$0.06Beat by $0.34

Ask the moment PAVmed Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did PAVmed Inc. report Q2 2025 earnings?
PAVmed Inc. (PAVM) reported Q2 2025 earnings on August 14, 2025 before market open.
What were PAVmed Inc.'s Q2 2025 revenue and EPS?
PAVmed Inc. reported revenue of $6.0K and diluted EPS of $-0.05 for Q2 2025.
Did PAVmed Inc. beat estimates in Q2 2025?
Revenue missed the consensus estimate of $10.0K by $4.0K. EPS beat the consensus estimate of $-0.25 by $0.20.
How did PAVmed Inc.'s Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 99.4% from $979.0K a year earlier and diluted EPS grew 94.0% from $-0.84.
Where can I find PAVmed Inc.'s Q2 2025 SEC filings?
You can read the 10-Q periodic report (0001493152-25-011923) directly on SEC EDGAR. The filing index links above go to sec.gov.